Data de publicação: 30/11/2021 - 12:23
Last Thursday (25 November) the Oswaldo Cruz Foundation, by means of its Immunobiological Technology Institute (Bio-Manguinhos/Fiocruz), submitted to the Brazilian Health Regulatory Agency (Anvisa) a request of post-registration alteration of its COVID-19 vaccine (recombinant), asking to include the Institute as the manufacturing unit of the Active Pharmaceutical Ingredient (API). Check out this 360º view of the production area for the...
Notícias
Data de publicação: 30/11/2021 - 11:47
In 2018, the king of the Yoruba people, Ooni of Ife, Oba Adeyeye Enitan Babatunde Ogunwus, visited Fiocruz and introduced the idea of a partnership in the field of traditional medicine and integrative health practices. Because of the COVID-19 pandemic, the conversation was stalled, but it was resumed this Wednesday (November 24th) with a visit of a delegation from the Palace of Ife to the Foundation.
(Photo: Pedro Paulo Gonç...
Notícias
Data de publicação: 29/11/2021 - 10:28
Severe cases of COVID-19 are related to the ageing of the immune system and to acute immunodeficiency. It is what the new study led by the Oswaldo Cruz Institute (IOC/Fiocruz) and by the Federal University of Rio de Janeiro (UFRJ) shows, published in the academic journal Journal of Infectious Diseases.
By analyzing blood samples of patients that have been hospitalized with the disease, the researchers detected signs of hyperactivity,...
Notícias
Data de publicação: 25/11/2021 - 13:58
“One mistake, one correction”: according to Carlos Morel, a researcher from the Brazilian state of Pernambuco, former Fiocruz president and current coordinator of the Center for Technological Development in Health (CDTS), this is how the world works. Last Tuesday (23 November), after attending the first meeting of the Scientific Advisory Group for the Origins of Novel Pathogens (SAGO), a group formed by the World Health Organization...
Notícias
Data de publicação: 25/11/2021 - 13:30
The first dose protects, but immunization requires a second dose and varies according to the age group and the time interval between doses. These are some conclusions of the pre-publication study that evaluated the effectiveness of the first dose of the AstraZeneca/Fiocruz vaccine against symptomatic cases of COVID-19 in the population of Complexo da Maré, in Rio de Janeiro (RJ). A 42.4% protection against symptomatic cases was estimated...
Notícias
Data de publicação: 22/11/2021 - 13:51
With two actions this week, Fiocruz became even more engaged in the fight against Hansen's, a neglected disease that had its situation aggravated during the COVID-19 pandemic. On Wednesday (11/17), the Foundation signed a Cooperation Agreement for joining the global campaign Don't Forget Hansen's Disease, with the state government and other partners, in addition to lighting the castle with purple at night as one of the actions to...
Notícias
Data de publicação: 17/11/2021 - 18:41
Sociologist and president of Fiocruz, Nísia Trindade Lima was appointed for The World Academy of Sciences for the advancement of science in developing countries (TWAS). The appointment was in the Academy’s General Meeting, on November 1st, as part of its 15th general conference.
Nísia is one of the 20 women who were appointed, in a total of 58 new members (Photo: Reproduction)
TWAS has the goal of bringing different...
Notícias
Data de publicação: 17/11/2021 - 18:24
There are a lot of statements, and a lot of commitments as well, but there is a lack of distinction of responsibilities and of the obligation in fulfilling the goals set, which hinders the operation of the G20. That is what the participants in the latest Advanced Seminar of the Fiocruz Global Health Center (CRIS/Fiocruz) point out. The G-20 Webinar: What we should expect from the richest people in the world in global and planetary health?...
Notícias
Data de publicação: 17/11/2021 - 18:03
In another huge step to the internationalization of education, Fiocruz updated the ordinance that regulates the dual-degree stricto sensu graduation program regime with foreign higher education institutions regarded as of strategic relevance for the Foundation, no. 508, of 2021. The initiative allows students to get dual-degrees or titles in master's and doctorate's degrees. With this regime, when finishing the program, the student...
Notícias
Data de publicação: 03/11/2021 - 11:51
Last Thursday (28 October) Fiocruz signed, during a ceremony that took place at the headquarters of AstraZeneca, in Cambridge, United Kingdom, a joint declaration of commitment for the acquisition of Active Pharmaceutical Ingredient (API) with the goal of producing 60 million doses of the COVID-19 vaccine (recombinant) in order to make up the deliveries of the Foundation for 2022. The commitment signed by the institutions aims to guarantee wide...
Notícias
Data de publicação: 03/11/2021 - 11:26
A new study published in Nature Communications last Thursday (28/11) shows that two doses of the AstraZeneca vaccine, produced in Brazil by Fiocruz, provide high protection against the Gamma variant in people above 60 years old. Based on São Paulo, the research shows that the second dose increases protection against death by about 30% when compared to the first dose, reaching an effectivity of 93.6%. Carried out by 20 researchers in...
Notícias
Data de publicação: 03/11/2021 - 09:39
Ten years after its signing, the Rio Political Declaration on Social Determinants of Health is more relevant than ever, as shown by the impacts of the COVID-19 pandemic in the world. To celebrate the document’s tenth anniversary and evaluate the approaches adopted since, two webinars held last Thursday (21 October) brought together many actors that were crucial for the negotiations that culminated in the declaration and for the quest for...
Notícias
Data de publicação: 29/10/2021 - 10:09
The team of the Viral Vaccines Laboratory of the National Institute for Quality Control in Health (INCQS/Fiocruz), which works with immunobiological drugs against rabies (LVV-Raiva), is participating in the second phase of an international study to replace potency assays in anti-rabies vaccines, traditionally made using mice for over 50 years.
Under code BSP148 and funded by the European Directorate for the Quality of Medicines and...
Notícias
Data de publicação: 27/10/2021 - 12:27
Production of the Fiocruz Active Pharmaceutical Ingredient (API) for COVID-19 vaccines is ongoing and is now moving on to a new and important phase of the process. Two pre-validation batches of the product manufactured by Fiocruz have been approved in all in-house quality tests and are now on their way to an external quality control at USA laboratories. At these labs, the samples will go through a complex testing process that involves 14 tests...
Notícias
Data de publicação: 27/10/2021 - 12:01
When Fiocruz joined the small summit of guest countries of the Global Sustainable Technology and Innovation Community (G-STIC) in 2018, the world still did not know Sars-CoV-2. Now, while the world population takes the vaccine for COVID-19, the fifth edition of the annual conference (the fourth with the participation of the Foundation), bets on a hybrid participation model from October 24th to 26th. The agenda includes both virtual and on-site...
Notícias
Data de publicação: 22/10/2021 - 09:48
Would it be possible to establish a new food model without the large producers' participation? Finding this answer is an ongoing global challenge and resounded in the seminar Food security, health and pandemics in United Nations events, organized by the Fiocruz Global Health Center (CRIS/Fiocruz). Divergent analyses and opinions revealed behind the scenes of international decisions on hunger programs and inspired empathy in provocative,...
Notícias
Data de publicação: 21/10/2021 - 13:21
Este relatório apresenta resultados preliminares da pesquisa “Covid-19, risco, impacto e resposta de gênero”, desenvolvida no Brasil pela Fiocruz e instituições parceiras1. Diversos temas relacionados aos impactos da pandemia da Covid-19 na vida das mulheres são contemplados pela pesquisa, mas este relatório concentra-se no tema da insegurança alimentar. São apresentados relatos...
Documento/Arquivo
Data de publicação: 20/10/2021 - 10:49
A cooperation that dates back to the beginning of the last century and that has been renovated and expanded over the decades was celebrated last Thursday (October 14th), with the visit of Portugal’s assistant secretary of Health, António Lacerda Sales, to Fiocruz. Accompanied by the Secretary of State of the Portuguese Communities, Berta Nunes, and by ambassador Luís Faro Ramos, among other members of the delegation, Sales...
Notícias
Data de publicação: 18/10/2021 - 16:03
After a one-year break due to the restrictions caused by the COVID-19 pandemic, the Fiocruz in Antarctica (Fioantar) project resumed its scientific excursions into the continent with a new departure this Wednesday morning (10/13). After a week of quarantine with actions to fight COVID-19, including diagnostic tests before and during the period, the Ary Rongel oceanographic support ship set sail to the Comandante Ferraz Antarctic Station carrying...
Notícias
Data de publicação: 18/10/2021 - 12:05
A study led by the Center for the Integration of Data and Knowledge on Health (Cidacs/Fiocruz Bahia) suggests that C-sections may be associated with a higher risk of infant mortality, with the exception of cases in which a medical indication is clear on this procedure, which is popularly known as “cesarean” in Brazil.
Photo: Courtesy
Using data collected and provided by the Ministry of Health on more than 17 million...
Notícias
Data de publicação: 16/10/2021 - 17:55
Sociologist and Fiocruz president, Nísia Trindade Lima, presented last Friday (October 8th) the conference Pandemic and Social Inequalities: Challenges for Global Health. The event was part of the Global Health Colloquium Series, a biannual series of lectures by Princeton University's Program in Global Health. Nísia thanked the university and Brazil Lab for the invitation, a hub that connects researchers and professors...
Notícias
Data de publicação: 13/10/2021 - 15:53
Fiocruz will be part, starting next week, of a Phase 3 international multicenter study with the drug Molnupiravir, manufactured by the pharmaceutical company MSD. The goal is to verify its efficiency to prevent the COVID-19 spread and transmission among people exposed to the Sars-CoV-2 virus. The study will occur simultaneously in seven centers in Brazil, two of which are under the Fiocruz responsibility: Mato Grosso do Sul and Rio de Janeiro....
Notícias
Data de publicação: 13/10/2021 - 13:47
On Thursday (September, 30th), the project for the installation of the Pharmaceutical Plant in Maputo, Mozambique capital, was concluded. The announcement was made in a joint statement by the Brazil and Mozambique governments and is the result of the technology transfer mission and partnership with the Institute of Technology in Medicines (Farmanguinhos/Fiocruz).
"We are finishing this important project with the merit of having left the...
Notícias
Data de publicação: 13/10/2021 - 11:13
The ambassador of Botswana to Brazil, Tebogo Montshome, visited Fiocruz last Thursday (October 7th). She decided to get to know the Foundation while visiting Rio de Janeiro to identify areas of possible cooperation between her country and the institution. Greeted by the Vice-President of Production and Innovation in Health, Marco Krieger, Montshome was particularly interested in staff training, research and production of drugs and vaccines....
Notícias
O conteúdo deste portal pode ser utilizado para todos os fins não comerciais, respeitados e reservados os direitos morais dos autores.
